McKinsey & Company to pay $650 million to settle U.S. opioid consulting probe

  • 📰 NECN
  • ⏱ Reading Time:
  • 44 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 21%
  • Publisher: 71%

Department Of Justice اخبار

ایران آخرین اخبار,ایران سرفصلها

McKinsey & Company agreed to pay $650 million in a deferred prosecution agreement that will resolve a federal criminal probe into the company's consulting work…

A former top partner at McKinsey has also agreed to plead guilty to obstruction of justice in the federal probe, according to court filings Friday

A press conference will be held at 12 p.m. at the Moakley Federal Courthouse in Boston, and will be livestreamed in the video player above., citing court filings, reported Friday morning that McKinsey has agreed to pay $650 million in a five-year deferred prosecution agreement that will resolve a federal criminal probe into the company's consulting work advising Purdue Pharma on how to"turbocharge" sales of its addictive opioid drug OxyContin.

According to the criminal charging document, McKinsey"knowingly and intentionally" conspired with Purdue Pharma"and others to aid and abet the misbranding of prescription drugs," CNBC reports. Through then-partner Elling, McKinsey is also accused of"knowingly destroying and concealing records and documents with the intent" to impede the DOJ's investigation.

این خبر را خلاصه کرده ایم تا بتوانید سریع آن را بخوانید. اگر به خبر علاقه مند هستید، می توانید متن کامل را اینجا بخوانید. ادامه مطلب:

 /  🏆 20. in İR
 

از نظر شما متشکرم. نظر شما پس از بررسی منتشر خواهد شد.

ایران آخرین اخبار, ایران سرفصلها